Zomedica Debt to Equity Ratio 2016-2023 | ZOM
Current and historical debt to equity ratio values for Zomedica (ZOM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Zomedica debt/equity for the three months ending September 30, 2023 was 0.00.
Zomedica Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-09-30 |
$0.01B |
$0.26B |
0.05 |
2023-06-30 |
$0.02B |
$0.26B |
0.06 |
2023-03-31 |
$0.02B |
$0.26B |
0.06 |
2022-12-31 |
$0.01B |
$0.27B |
0.05 |
2022-09-30 |
$0.01B |
$0.27B |
0.05 |
2022-06-30 |
$0.01B |
$0.27B |
0.04 |
2022-03-31 |
$0.01B |
$0.27B |
0.03 |
2021-12-31 |
$0.01B |
$0.27B |
0.04 |
2021-09-30 |
$0.01B |
$0.27B |
0.02 |
2021-06-30 |
$0.00B |
$0.28B |
0.02 |
2021-03-31 |
$0.00B |
$0.28B |
0.01 |
2020-12-31 |
$0.02B |
$0.05B |
0.30 |
2020-09-30 |
$0.00B |
$0.05B |
0.06 |
2020-06-30 |
$0.00B |
$0.03B |
0.11 |
2020-03-31 |
$0.00B |
$0.00B |
1.58 |
2019-12-31 |
$0.00B |
$0.00B |
1.00 |
2019-09-30 |
$0.00B |
$0.01B |
0.31 |
2019-06-30 |
$0.00B |
$0.01B |
0.23 |
2019-03-31 |
$0.01B |
$-0.00B |
-4.14 |
2018-12-31 |
$0.00B |
$0.00B |
0.65 |
2018-09-30 |
$0.00B |
$0.00B |
0.44 |
2018-06-30 |
$0.00B |
$0.01B |
0.36 |
2018-03-31 |
$0.00B |
$0.00B |
0.35 |
2017-12-31 |
$0.00B |
$0.00B |
0.19 |
2017-09-30 |
$0.00B |
$0.00B |
0.00 |
2017-06-30 |
$0.00B |
$0.00B |
0.00 |
2017-03-31 |
$0.00B |
$0.00B |
0.00 |
2016-12-31 |
$0.00B |
$0.00B |
0.19 |
2015-12-31 |
$0.00B |
$0.00B |
0.04 |
Sector |
Industry |
Market Cap |
Revenue |
Basic Materials |
Gold Miners |
$0.141B |
$0.019B |
Zomedica Corp. is a veterinary health company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica Corp., formerly known as Zomedica Pharmaceuticals Corp., is based in Ann Arbor, Michigan.
|